Opioid treatment options
Pro Research Analysisby 
Searched over 200M research papers
Opioid Treatment Options: A Comprehensive Overview
Pharmacological Treatments for Opioid Dependence
Opioid Agonists: Methadone and Buprenorphine
Methadone and buprenorphine are the most commonly used medications for opioid use disorder (OUD). Methadone, a full opioid agonist, and buprenorphine, a partial agonist, work by suppressing withdrawal symptoms and reducing cravings. Methadone has the strongest evidence for effectiveness, particularly when used over a longer duration, which helps restore social connections and improve outcomes2 9. Buprenorphine, available in long-acting formulations, is also effective and can be administered in office-based settings, making it more accessible9.
Opioid Antagonists: Naltrexone
Naltrexone, an opioid antagonist, blocks the effects of opioids and is used to prevent relapse. Extended-release formulations of naltrexone have shown promise in improving retention and sustained abstinence, although more randomized clinical trials are needed to confirm these findings9. Naltrexone is particularly useful for patients who have already undergone detoxification and are committed to maintaining abstinence2.
Non-Opioid Pharmacotherapies
Alpha-2 adrenergic agonists, such as clonidine and lofexidine, are used to manage withdrawal symptoms. These medications are less effective than opioid agonists but can be useful in certain clinical scenarios, such as when transitioning patients from methadone to buprenorphine or stabilizing patients for extended-release naltrexone7.
Emerging Pharmacological Treatments
Newer agents like tramadol and tizanidine are being explored for their potential in managing opioid withdrawal. Additionally, alternative medications such as ketamine, cannabinoids, and noribogaine are under investigation for their potential to treat OUD and withdrawal symptoms. These alternative treatments show promise but require more research to establish their efficacy and safety7 8.
Psychosocial Interventions
Integrated Behavioral Treatments
Psychosocial approaches are crucial in the treatment of OUD. Integrated treatments that combine behavioral therapies with pharmacological interventions have shown significant benefits. For instance, Acceptance and Commitment Therapy (ACT) combined with Mindfulness-Based Relapse Prevention (MBRP) has been effective in reducing opioid misuse and pain interference among veterans with chronic pain4. Similarly, Mindfulness-Oriented Recovery Enhancement (MORE) has demonstrated efficacy in reducing pain severity and opioid misuse, although the long-term effects need further investigation6.
Harm Reduction and Low Threshold Treatments
Harm reduction strategies, such as opioid substitution therapy (OST) with methadone, buprenorphine, or slow-release oral morphine (SROM), are recommended for individuals who do not respond to traditional treatments. Heroin-assisted treatment using diamorphine is also considered a cost-effective alternative for increasing retention and reducing illicit opioid use3. Low threshold treatment designs, which focus on increasing accessibility and personalized treatment options, have shown better outcomes compared to high threshold designs5.
Conclusion
The treatment of opioid use disorder involves a combination of pharmacological and psychosocial interventions. Methadone and buprenorphine remain the gold standards for pharmacological treatment, while naltrexone offers an alternative for relapse prevention. Emerging treatments and integrated behavioral approaches provide additional options for managing OUD. Expanding access to these treatments and reducing barriers to care are essential for improving outcomes and addressing the opioid epidemic effectively.
Sources and full results
Most relevant research papers on this topic
A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction.
Opioid dependence treatment options include pharmacological and psychosocial interventions, with evidence supporting the inclusion of psychosocial approaches in treatment regimens.
Systematic Review
Highly CitedMedication Treatment of Opioid Use Disorder
Methadone, buprenorphine, and naltrexone are effective medications for opioid use disorder, but access and stigma limit their use.
Very Rigorous JournalHighly CitedNew Approaches in Drug Dependence: Opioids
Oral opioid substitution treatment and heroin-assisted therapies are effective for opioid addiction, but more research is needed on psychological interventions and harm reduction.
Literature ReviewIntegrated behavioral treatment for Veterans with co-morbid chronic pain and hazardous opioid use: A randomized controlled pilot trial.
An integrated behavioral treatment combining Acceptance and Commitment Therapy for chronic pain and Mindfulness Based Relapse Prevention for opioid misuse is feasible and shows initial efficacy in Veterans with opioid-related issues.
RCTOpioid substitution therapy: Lowering the treatment thresholds.
Low threshold opioid substitution therapy designs, which include increased accessibility, personalized medication choices, flexible duration, and harm reduction, show better treatment outcomes compared to high threshold designs.
Systematic ReviewHighly CitedMindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
Mindfulness-Oriented Recovery Enhancement (MORE) shows preliminary feasibility and efficacy in treating co-occurring prescription opioid misuse and chronic pain.
RCTHighly CitedNew directions in the treatment of opioid withdrawal
Opioid withdrawal treatment with -opioid receptor agonists, partial agonists, and 2-adrenergic receptor agonists is effective for chronic pain, opioid use disorder, and opioid use disorder patients.
Rigorous JournalHighly CitedHistorical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review.
Ketamine shows promise in treating opioid addiction, while cannabinoids show potential for treating various illnesses, but more research is needed to confirm their effectiveness.
Literature ReviewRigorous JournalOpioid dependence treatment: options in pharmacotherapy
Pharmacotherapies for opioid dependence include agonist maintenance therapy, buprenorphine, and sustained-release naltrexone, with agonist maintenance being the recommended treatment and detoxification having limited long-term efficacy.
Highly Cited